SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 74.65 |
Enterprise Value ($M) | 173.54 |
Book Value ($M) | -211.32 |
Book Value / Share | -1.15 |
Price / Book | -0.35 |
NCAV ($M) | -271.89 |
NCAV / Share | -1.48 |
Price / NCAV | -0.27 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | -0.87 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.13 |
Current Ratio | 0.14 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 39.85 |
Assets | 100.43 |
Liabilities | 311.75 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | SCLX Stock Acquisition JV LLC | |||
13G | Oramed Pharmaceuticals Inc. |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
133,292 | 781,459 | 17.06 | |
292,358 | 1,180,201 | 24.77 | |
589,309 | 2,920,104 | 20.18 | |
37,815 | 314,010 | 12.04 | |
(click for more detail) |
Similar Companies | |
---|---|
SABS – SAB Biotherapeutics, Inc. | SAVA – Cassava Sciences, Inc. |
SBFM – Sunshine Biopharma, Inc. | SGMO – Sangamo Therapeutics, Inc. |
SHPH – Shuttle Pharmaceuticals Holdings, Inc. |
Financial data and stock pages provided by
Fintel.io